The Latin America, Middle East and Africa Carrier Screening Market would witness market growth of 11.47% CAGR during the forecast period (2021-2027).
Predictive/presymptomatic testing refers to the identification of the risk, before the beginning of the symptoms. The majority of the genetic disorders can be identified early during the pregnancy stage. Hence, the growth of the overall carrier screening market would be driven by the high consumer demand for secure and efficient carrier tests. Additionally, the market would be benefitted commercially due to the massive adoption of carrier tests into regular clinical care. As per many studies, early detection of diseases can avoid them wholly or at least reduce the complexities of the diseases. Healthcare firms in numerous countries are funding newborn screening to foresee the possibilities of diseases such as cancers, which would happen later in adulthood.
The growing demand for advanced healthcare systems or devices in the region is expected to create bright prospects for regional growth. Along with this, the increasing disposable income of consumers in some emerging nations of this region would also contribute to the demand for advanced diagnosis methods like carrier screening due to their willingness to spend high on different healthcare solutions.
In addition, the rising focus of many manufacturers of the region on improving the technologies will also help them to create advanced and cost-effective carrier screening procedures that would further positively impact the growth of the regional carrier screening market.
The Brazil market dominated the LAMEA Other End user Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $3.1 million by 2027. The Argentina market is showcasing a CAGR of 15.5% during (2021 - 2027). Additionally, The UAE market is anticipated to grow at a CAGR of 14.1% during (2021 - 2027).
Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Carrier Screening Market is Predict to reach $2,501.94 Million by 2027, at a CAGR of 10.81%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Expanded Carrier Screening and
- Targeted Disease Carrier Screening
By Technology
- DNA Sequencing
- Microarrays
- Polymerase Chain Reaction and
- Other technology
By End User
- Hospital and Clinics
- Physician Offices
- Reference Laboratories and
- Other End Users
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Quest Diagnostics, Incorporated
- Thermo Fisher Scientific
- Illumina, Inc.
- Eurofins Scientific Group
- Invitae Corporation
- OPKO Health, Inc.
- Fulgent Genetics
- Sema4 OpCo, Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Carrier Screening Market, by Type
1.4.2 LAMEA Carrier Screening Market, by Technology
1.4.3 LAMEA Carrier Screening Market, by End User
1.4.4 LAMEA Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. LAMEA Carrier Screening Market by Type
4.1 LAMEA Expanded Carrier Screening Market by Country
4.2 LAMEA Targeted Disease Carrier Screening Market by Country
Chapter 5. LAMEA Carrier Screening Market by Technology
5.1 LAMEA DNA Sequencing Market by Country
5.2 LAMEA Microarrays Market by Country
5.3 LAMEA Polymerase Chain Reaction Market by Country
5.4 LAMEA Other Technologies Market by Country
Chapter 6. LAMEA Carrier Screening Market by End user
6.1 LAMEA Hospital and Clinics Market by Country
6.2 LAMEA Physician Offices Market by Country
6.3 LAMEA Reference Laboratories Market by Country
6.4 LAMEA Other End user Market by Country
Chapter 7. LAMEA Carrier Screening Market by Country
7.1 Brazil Carrier Screening Market
7.1.1 Brazil Carrier Screening Market by Type
7.1.2 Brazil Carrier Screening Market by Technology
7.1.3 Brazil Carrier Screening Market by End user
7.2 Argentina Carrier Screening Market
7.2.1 Argentina Carrier Screening Market by Type
7.2.2 Argentina Carrier Screening Market by Technology
7.2.3 Argentina Carrier Screening Market by End user
7.3 UAE Carrier Screening Market
7.3.1 UAE Carrier Screening Market by Type
7.3.2 UAE Carrier Screening Market by Technology
7.3.3 UAE Carrier Screening Market by End user
7.4 Saudi Arabia Carrier Screening Market
7.4.1 Saudi Arabia Carrier Screening Market by Type
7.4.2 Saudi Arabia Carrier Screening Market by Technology
7.4.3 Saudi Arabia Carrier Screening Market by End user
7.5 South Africa Carrier Screening Market
7.5.1 South Africa Carrier Screening Market by Type
7.5.2 South Africa Carrier Screening Market by Technology
7.5.3 South Africa Carrier Screening Market by End user
7.6 Nigeria Carrier Screening Market
7.6.1 Nigeria Carrier Screening Market by Type
7.6.2 Nigeria Carrier Screening Market by Technology
7.6.3 Nigeria Carrier Screening Market by End user
7.7 Rest of LAMEA Carrier Screening Market
7.7.1 Rest of LAMEA Carrier Screening Market by Type
7.7.2 Rest of LAMEA Carrier Screening Market by Technology
7.7.3 Rest of LAMEA Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
TABLE 1 LAMEA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Carrier Screening Market
TABLE 4 Product Launches And Product Expansions– Carrier Screening Market
TABLE 5 Acquisition and Mergers– Carrier Screening Market
TABLE 6 LAMEA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 7 LAMEA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 8 LAMEA Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 9 LAMEA Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 10 LAMEA Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 11 LAMEA Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 12 LAMEA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 13 LAMEA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 14 LAMEA DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 15 LAMEA DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 16 LAMEA Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 17 LAMEA Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 18 LAMEA Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 19 LAMEA Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 20 LAMEA Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 21 LAMEA Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 22 LAMEA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 23 LAMEA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 24 LAMEA Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 25 LAMEA Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 26 LAMEA Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 27 LAMEA Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 28 LAMEA Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 29 LAMEA Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 30 LAMEA Other End user Market by Country, 2017 - 2020, USD Million
TABLE 31 LAMEA Other End user Market by Country, 2021 - 2027, USD Million
TABLE 32 LAMEA Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 33 LAMEA Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 34 Brazil Carrier Screening Market, 2017 - 2020, USD Million
TABLE 35 Brazil Carrier Screening Market, 2021 - 2027, USD Million
TABLE 36 Brazil Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 37 Brazil Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 38 Brazil Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 39 Brazil Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 40 Brazil Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 41 Brazil Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 42 Argentina Carrier Screening Market, 2017 - 2020, USD Million
TABLE 43 Argentina Carrier Screening Market, 2021 - 2027, USD Million
TABLE 44 Argentina Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 45 Argentina Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 46 Argentina Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 47 Argentina Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 48 Argentina Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 49 Argentina Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 50 UAE Carrier Screening Market, 2017 - 2020, USD Million
TABLE 51 UAE Carrier Screening Market, 2021 - 2027, USD Million
TABLE 52 UAE Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 53 UAE Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 54 UAE Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 55 UAE Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 56 UAE Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 57 UAE Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 58 Saudi Arabia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 59 Saudi Arabia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 60 Saudi Arabia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 61 Saudi Arabia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 62 Saudi Arabia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 63 Saudi Arabia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 64 Saudi Arabia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 65 Saudi Arabia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 66 South Africa Carrier Screening Market, 2017 - 2020, USD Million
TABLE 67 South Africa Carrier Screening Market, 2021 - 2027, USD Million
TABLE 68 South Africa Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 69 South Africa Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 70 South Africa Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 71 South Africa Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 72 South Africa Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 73 South Africa Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 74 Nigeria Carrier Screening Market, 2017 - 2020, USD Million
TABLE 75 Nigeria Carrier Screening Market, 2021 - 2027, USD Million
TABLE 76 Nigeria Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 77 Nigeria Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 78 Nigeria Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 79 Nigeria Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 80 Nigeria Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 81 Nigeria Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 82 Rest of LAMEA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 83 Rest of LAMEA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 84 Rest of LAMEA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 85 Rest of LAMEA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 86 Rest of LAMEA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 87 Rest of LAMEA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 88 Rest of LAMEA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 89 Rest of LAMEA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 90 Key Information – Quest Diagnostics, Incorporated
TABLE 91 Key Information – Thermo Fisher Scientific, Inc.
TABLE 92 key information – Illumina, Inc.
TABLE 93 Key Information – Eurofins Scientific Group
TABLE 94 Key Information – Invitae Corporation
TABLE 95 Key Information – OPKO Health, Inc.
TABLE 96 Key Information – Fulgent Genetics
TABLE 97 Key Information – Sema4 OpCo, Inc.
TABLE 98 Key Information – Myriad Genetics, Inc.
TABLE 99 Key Information – Natera Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Quest Diagnostics
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Sema4 OpCo, Inc.